The GlucoRx BioXensor non-invasive continuous glucose monitor (CGM) will soon be doing the rounds at major exhibitions in Germany, the UK, and the US. The blood sugar monitor has been under development for around a decade and has delivered promising results in clinical studies. The BioXensor CGM could be an affordable management solution for millions of diabetics.